Investigating the effects of obesity and metabolic syndrome on asthma and airway health

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study aims to explore the relationship between obesity, metabolic syndrome, and airway nitric oxide biology in asthmatic patients. It will compare metabolic pathways in bronchial airway epithelial cells and nasal epithelium among four distinct groups: obese asthmatics without metabolic syndrome, obese asthmatics with metabolic syndrome, obese non-asthmatics, and non-obese asthmatics. Participants will undergo lung function testing, bronchoscopy, and nasal epithelial brush sampling to assess gene expression. The study will match participants by gender, age, and asthma severity to ensure comparability.

Why it matters

Who can join: the full rules

Inclusion Criteria:

For ALL Groups

1. Adequate completion of informed consent process with written documentation
2. Male and female patients, ≥ 18 - 65 years old
3. Smoking history \<10 pack years and no smoking in the last year

   \*\*Subjects can be included in the study if they are on blood pressure treatment and are on a diet control/exercise only treatment of diabetes.
4. Specific to Asthma Groups

i. From all racial/ethnic backgrounds with a diagnosis of asthma based on physician diagnosis for \>6 months

1. Specific to Metabolic Syndrome Group. Metabolic syndrome diagnosis based on having at least any three of: a. Triglycerides ≥ 150 mg/dl; b. High-density lipoproteins (HDL) cholesterol ≤ 50 mg/dl for women and ≤ 40 mg/dl for men; c Fasting blood glucose ≥ 100 mg/dl; d. Waist circumference \> 40 inches males and \> 35 inches females); e. Previously diagnosed hypertension or on antihypertensive medication; f. Blood pressure greater than 130/85 on two consecutive measurements.
2. Specific to Non-Metabolic Syndrome Group a. Baseline pre-bronchodilator forced expiratory volume (FEV1) of 50% or greater of predicted with a 12% or greater bronchodilator (BD) response to 4 puffs of albuterol or PC20 methacholine (16 mg) if no BD response; b. BMI ≥ 30

   Metabolic syndrome diagnosis based on having at least any three of:

   i. Triglycerides ≥ 150 mg/dl; ii. HDL cholesterol ≤ 50 mg/dl for women and ≤ 40 mg/dl for men; iii. Fasting blood glucose ≥ 100 mg/dl; iv. Waist circumference \> 40 inches males and \> 35 inches females); v. Previously diagnosed hypertension or on antihypertensive medication; vi. Blood pressure greater than 130/85 on two consecutive measurements.
3. Specific to Non-Obese Group a. Body Mass Index (BMI) \< 30

   b. Specific to Non-Asthma Group i. No history of asthma or any other airway diseases; ii. Pulmonary function test within normal limits; iii. BMI ≥ 30.

Exclusion Criteria (all groups):

1. Significant or uncontrolled concomitant medical illness (PI discretion) including, but not limited to heart disease, cancer, diabetes (HbAc1 \> 6.5), renal disease (creatinine \> 2.0) at Visit 0, neurological (brain damage) or psychiatric disorder (diagnosed by a mental health professional of behavioral or mental pattern that may cause suffering or a poor ability to function in life);
2. Chronic renal failure (creatinine \> 2.0) at screening (associated with higher asymmetric dimethylarginine (ADMA) levels);
3. Current statins use (statins lower ADMA levels);
4. On diabetic medications;
5. Positive pregnancy test;
6. Positive urine cotinine and/or urine tetrahydrocannabinol (THC) test;
7. Current or recent (within 30 days) investigational treatment or participation in another interventional research study (including non-pharmacologic interventions);
8. Unable or unlikely to complete study assessments or the study intervention (i.e. bronchoscopy) poses undue risk to patient in the opinion of the investigator.

   a. Specific to Asthma Groups i. Respiratory tract infection within the last 4 weeks; ii. Oral or systemic corticosteroids (CS) burst within the last 4 weeks; iii. Asthma-related hospitalization within the last 2 months; iv. Asthma-related ER visit within the previous 4 weeks.

Where it's running

• University of Colorado
  Aurora, Colorado, United States Recruiting

Study contacts

• Principal investigator: Fernando Holguin, MD, MPH — University of Colorado Denver, Anschutz Medical Campus
• Study coordinator: Asthma Research
• Email: asthmaresearch@ucdenver.edu
• Phone: 1 (844) 365-0852

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients

  This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.

  Recruiting Zhangzhou Municipal Hospital · Zhangzhou, Fujian · NCT07836088

• Rutazyme lemon fermented capsules for metabolic health in adults with obesity

  This will test whether taking a Rutazyme lemon fermented capsule each night can help improve metabolic health in adults with obesity.

  Recruiting National Taiwan Sport University · Taoyuan · NCT07540949

• How moderate wine drinking affects healthy aging through post-meal extracellular vesicles

  This test will see if a single serving of red or white wine changes circulating extracellular vesicles in healthy adults aged 35–65.

  Recruiting University of Seville · Seville, Sevilla · NCT07361887

• Pre-screening to identify adults who may be eligible for future metabolic and mental health opportunities.

  This prescreening will see if adults with metabolic conditions or mental health disorders qualify for upcoming clinical opportunities by collecting health history, basic tests, and a doctor interview.

  Recruiting Clindove Research LLC · Brooklyn, New York · NCT07106879

• Investigating inflammation's role in heart disease and diabetes

  This study is testing how inflammation affects heart disease and diabetes in people who are healthy compared to those who are severely obese, to see if it can help identify who might benefit from new treatments.

  Recruiting University of Aarhus · Aarhus · NCT06752018

• Integrated Traditional Chinese Medicine Program for Metabolic Syndrome

  This study is testing a combined approach of Chinese herbal medicine and laser acupuncture to see if it can help people with metabolic syndrome improve their health over six months.

  Recruiting Phase 1/2 Chang Gung Memorial Hospital · Taoyuan · NCT06703788

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.